| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 814 |
| 1 | INFLIXIMAB | 387 |
| 2 | AZATHIOPRINE | 277 |
| 3 | VEDOLIZUMAB | 252 |
| 4 | METHOTREXATE SODIUM | 226 |
| 5 | PREDNISONE | 204 |
| 6 | METHOTREXATE | 195 |
| 7 | USTEKINUMAB | 157 |
| 8 | ADALIMUMAB-ADAZ | 138 |
| 9 | ADALIMUMAB-AATY | 126 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | POTASSIUM CHLORIDE AND SODIUM CHLORIDE | 1 | 0.0167 |
| 1 | INFLIXIMAB-DYYB | 52 | 0.0151 |
| 2 | HYDROXYPROGESTERONE CAPROATE | 1 | 0.0075 |
| 3 | USTEKINUMAB-AUUB | 1 | 0.0057 |
| 4 | USTEKINUMAB-TTWE | 1 | 0.0052 |
| 5 | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE | 1 | 0.0049 |
| 6 | COSYNTROPIN | 1 | 0.0045 |
| 7 | .ALPHA.-TOCOPHEROL ACETATE, DL-, ASCORBIC ACID, CYANOCOBALAMIN, FOLIC ACID, NIACIN, PYRIDOXINE, RIBOFLAVIN, SODIUM FLUORIDE, THIAMINE MONONITRATE, VITAMIN A AND VITAMIN D | 1 | 0.0045 |
| 8 | ADALIMUMAB-RYVK | 4 | 0.0037 |
| 9 | MESALAMINE | 91 | 0.0032 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 549 |
| 1 | Corticosteroid [EPC] | 398 |
| 2 | Purine Antimetabolite [EPC] | 277 |
| 3 | Integrin Receptor Antagonist [EPC] | 257 |
| 4 | Interleukin-23 Antagonist [EPC] | 233 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 200 |
| 6 | Interleukin-12 Antagonist [EPC] | 160 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 125 |
| 8 | Aminosalicylate [EPC] | 114 |
| 9 | Proton Pump Inhibitor [EPC] | 89 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Integrin Receptor Antagonist [EPC] | 257 | 0.0030 |
| 1 | Purine Antimetabolite [EPC] | 277 | 0.0028 |
| 2 | Provitamin D2 Compound [EPC] | 82 | 0.0028 |
| 3 | Vitamin B6 Analog [EPC] | 1 | 0.0028 |
| 4 | Interleukin-23 Antagonist [EPC] | 233 | 0.0022 |
| 5 | Bile Acid Sequestrant [EPC] | 22 | 0.0018 |
| 6 | Interleukin-12 Antagonist [EPC] | 160 | 0.0015 |
| 7 | Aminosalicylate [EPC] | 114 | 0.0011 |
| 8 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 9 | Nitroimidazole Antimicrobial [EPC] | 37 | 0.0006 |